Moderna shares rise 6% after the FDA reversed its decision not to review the flu vaccine
Following an earlier surge in pre-market trading, Moderna shares increased 6.4% to approximately $46.75 shortly after the market started on...
Moderna
Moderna’s stock surges when Oppenheimer suggests that the developer of the Covid vaccine may release more goods in the next two years
Tuesday saw a more than 13% increase in Moderna shares after Oppenheimer upgraded the stock to "outperform," stating that the...
Moderna vaccine outperforms in early-stage skin cancer trials
Following the success of its mRNA vaccine for COVID-19, Moderna reported on December 13 that it had produced promising results...
